Vivani Medical Files 8-K
Ticker: VANI · Form: 8-K · Filed: Jun 13, 2024 · CIK: 1266806
Sentiment: neutral
Topics: 8-k, filing, financials
TL;DR
Vivani Medical filed an 8-K on June 7th, standard update, nothing major to see here.
AI Summary
Vivani Medical, Inc. filed an 8-K on June 13, 2024, reporting other events and financial statements as of June 7, 2024. The filing details the company's operations and financial status without specifying any major transactions or events.
Why It Matters
This 8-K filing provides an update on Vivani Medical's corporate and financial status, which is important for investors to monitor the company's ongoing activities.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not indicate any significant new risks or material adverse events.
Key Players & Entities
- Vivani Medical, Inc. (company) — Registrant
- June 7, 2024 (date) — Earliest event reported date
- June 13, 2024 (date) — Filing date
- 1350 S. Loop Road (address) — Principal executive offices
- Alameda, California 94502 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing for Vivani Medical, Inc.?
The primary purpose of this 8-K filing is to report 'Other Events' and 'Financial Statements and Exhibits' as of June 7, 2024.
When was the earliest event reported in this filing?
The earliest event reported in this filing was on June 7, 2024.
What is the filing date of this 8-K report?
This 8-K report was filed on June 13, 2024.
What is Vivani Medical, Inc.'s principal executive office address?
Vivani Medical, Inc.'s principal executive office is located at 1350 S. Loop Road, Alameda, California 94502.
What is the telephone number listed for Vivani Medical, Inc.'s agent for service?
The telephone number listed for Vivani Medical, Inc.'s agent for service is (415) 506-8462.
Filing Stats: 476 words · 2 min read · ~2 pages · Grade level 10.2 · Accepted 2024-06-13 08:01:51
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share VANI Nasdaq Capital Mark
Filing Documents
- g084283_8k.htm (8-K) — 30KB
- g084283_ex99-1.htm (EX-99.1) — 15KB
- 0001753926-24-001110.txt ( ) — 219KB
- vani-20240607.xsd (EX-101.SCH) — 3KB
- vani-20240607_lab.xml (EX-101.LAB) — 33KB
- vani-20240607_pre.xml (EX-101.PRE) — 22KB
- g084283_8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press release issued by Vivani Medical, Inc. on June 13, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. VIVANI MEDICAL, INC. Date: June 13, 2024 By: /s/ Brigid A. Makes Name: Brigid A. Makes Title: Chief Financial Officer